SYMPTOMATIC VENOUS THROMBOEMBOLISM (VTE)

Clinical trials for SYMPTOMATIC VENOUS THROMBOEMBOLISM (VTE) explained in plain language.

Never miss a new study

Get alerted when new SYMPTOMATIC VENOUS THROMBOEMBOLISM (VTE) trials appear

Sign up with your email to follow new studies for SYMPTOMATIC VENOUS THROMBOEMBOLISM (VTE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Race for safer blood clot prevention after surgery

Prevention Recruiting now

This study is testing if an experimental drug called REGN7508 works better than aspirin to prevent dangerous blood clots in the legs or lungs after a planned knee replacement surgery. It will involve 2,000 adults who are having this elective surgery. The main goal is to see which…

Matched conditions: SYMPTOMATIC VENOUS THROMBOEMBOLISM (VTE)

Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Prevention

Last updated Mar 27, 2026 12:37 UTC

SYMPTOMATIC VENOUS THROMBOEMBOLISM (VTE)

Get alerted when new SYMPTOMATIC VENOUS THROMBOEMBOLISM (VTE) trials appear

Race for safer blood clot prevention after surgery